|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment loss (Note 10) | |||||
| Movement in allowance for credit losses | |||||
| Fair value adjustment related to financial liabilities | |||||
| Change in fair value of equity securities (Note 6 and 9) | |||||
| Gain on disposal of equity securities (9) | |||||
| Other income | |||||
| Loss on disposal of equity securities (Note 3) | |||||
| Loss on disposal of equity-accounted investment (Note 9) | |||||
| Gain on deconsolidation of subsidiary | |||||
| (Profit) Loss on disposal of property, plant and equipment | |||||
| Stock-based compensation charge (Note 17) | |||||
| (Earnings) Loss from equity-accounted investments (Note 9) | |||||
| Reversal of allowance for doubtful loans | |||||
| Dividends received from equity-accounted investments | |||||
| Interest payable | |||||
| Facility fee amortized (Note 12) | |||||
| Increase (Decrease) in income taxes payable | |||||
| Deferred tax benefit | |||||
| Decrease (Increase) in accounts receivable (Note 20) | |||||
| Increase in finance loans receivable (Note 20) | |||||
| Decrease in inventory | |||||
| Increase (Decrease) in accounts payable and other payables | |||||
| Deferred consideration included in other payables (Note 3 and Note 13) | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Acquisition of intangible assets | |||||
| Acquisitions, net of cash acquired (Note 3) | |||||
| Proceeds from disposal of equity securities (Note 6 and 9) | |||||
| Investment in equity securities | |||||
| Cash disposed on disposal of subsidiary | |||||
| Proceeds from disposal of equity-accounted investment (Note 9) | |||||
| Bank Frick | |||||
| Total proceeds from disposal of equity-accounted investment (Note 9) | |||||
| Repayment of loans by equity-accounted investments | |||||
| Loans to equity-accounted investment (Note 9) | |||||
| Acquisition of insurance entity investments | |||||
| Net change in settlement assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from bank overdraft (Note 12) | |||||
| Repayment of bank overdraft (Note 12) | |||||
| Long-term borrowings utilized (Note 12) | |||||
| Repayment of long-term borrowings (Note 12) | |||||
| Non-refundable deal origination fees/ guarantee fees (Note 12) | |||||
| Repurchase of shares of common stock and treasury stock (Note 14) | |||||
| Proceeds from exercise of stock options | |||||
| Acquisition of non-controlling interests (Note 14) | |||||
| Dividends paid to non-controlling interest | |||||
| Net change in settlement obligations | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash - beginning of period | |||||
| Cash, cash equivalents and restricted cash - end of period (Note 20) | |||||
Loading...